معرفی
Rafael Bayarri Olmos is an Associate Research Scientist at Yale University's Yale School of Medicine, affiliated with the Department of Immunobiology. He holds a PhD in Molecular Immunology from Copenhagen University and focuses on immunology, virology, and complement system biology. His research emphasizes SARS-CoV-2 immunity, antibody responses, and complement pathway modulation, with notable studies on Omicron variant impacts and vaccine efficacy in immunocompromised populations.
Education: PhD (Copenhagen University, 2018), MSc (Copenhagen University, 2013), BSc (University of León, 2011).
Key Research: Investigates viral immune evasion mechanisms, complement system regulation, and translational therapies for infectious diseases. Leads projects on SARS-CoV-2 antibody dynamics, lectin pathway activation in critical illness, and chimeric protein-based immunomodulators.
Publications (2022-2023): 10+ peer-reviewed articles in Journal of Innate Immunity, Microbiology Spectrum, and FASEB Journal, covering complement inhibitors, Omicron immunity, and vaccine response optimization.
Labs: Active in the Iwasaki Lab, focusing on immune system interactions with pathogens and therapeutic development.
